The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days in a large study led by the U.S. National Institutes of Health.
↧
Channel:
CommonHealth
X
Are you the publisher?
Claim or
contact us
about this channel.
X
0
Channel Details:
- Title: CommonHealth
- Channel Number: 19688332
- Language: English
- Registered On: June 29, 2013, 12:55 pm
- Number of Articles: 2298
- Latest Snapshot: July 20, 2021, 4:56 pm
- RSS URL: http://commonhealth.wbur.org/tag/pharmaceuticals/feed
- Publisher: http://www.wbur.org/commonhealth
- Description: News and smart analysis on all things health
- Catalog: //commonhealth66.rssing.com/catalog.php?indx=19688332
© 2025 //www.rssing.com